Shares of ValiRx plc (LON:VAL – Get Free Report) dropped 13.2% on Monday . The company traded as low as GBX 0.46 ($0.01) and last traded at GBX 0.46 ($0.01). Approximately 500,220 shares were traded during trading, a decline of 93% from the average daily volume of 7,385,600 shares. The stock had previously closed at GBX 0.53 ($0.01).
ValiRx Trading Up 5.6 %
The stock has a market cap of £2.00 million, a P/E ratio of -0.36 and a beta of 0.59. The company has a 50-day simple moving average of GBX 0.59 and a 200-day simple moving average of GBX 0.97. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.27 and a current ratio of 6.65.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- 3 Fintech Stocks With Good 2021 Prospects
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- Overbought Stocks Explained: Should You Trade Them?
- Congress! Who Traded What During the Tariff-Induced Meltdown
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
